Nano-biotechnology and its Innovative Perspective in Diabetes Management / Jigar Raval, Riddhi Trivedi, Sonali Suman, Arvind Kukrety, Prajesh Prajapati
Abstract: The occurrence of the diabetes happens due to the irregular operation of glucose in thebody, which is also known as glucose homeostasis, thus leading to metabolic changes in the body. Thetwo stages whether hypoglycemia or hyperglycemia differentiates diabetes into various categories andbrought new innovative management for the new routes of administration of these disease condition.Various bio-nanotechnologies which are coupled with nano particulates, polymers, Liposome, variousgold plated and Solid Lipids Particulates regulate the transcellular transport, non specific cellular uptake,and paracellular transport, which leads to oral, transdermal, Pulmonary, buccal, Nasal, specificgene oriented administration to avoid the non patience compliance with the parental routes of administration.Phytochemicals have an emerging strategy for the future prospects of diabetes management.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Mini-reviews in ... medicinal chemistry - 22(2022), 1, Seite 26 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Raval, Jigar [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (26 p) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL011180099 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL011180099 | ||
| 003 | DE-627 | ||
| 005 | 20231128075953.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230613s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL011180099 | ||
| 035 | |a (KFL)prod_DARH_.47FB2900292E9C708D14ED3D3AB04346D97237B6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Raval, Jigar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nano-biotechnology and its Innovative Perspective in Diabetes Management |c Jigar Raval, Riddhi Trivedi, Sonali Suman, Arvind Kukrety, Prajesh Prajapati |
| 264 | 1 | |c 2022 | |
| 300 | |a 1 Online-Ressource (26 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract: The occurrence of the diabetes happens due to the irregular operation of glucose in thebody, which is also known as glucose homeostasis, thus leading to metabolic changes in the body. Thetwo stages whether hypoglycemia or hyperglycemia differentiates diabetes into various categories andbrought new innovative management for the new routes of administration of these disease condition.Various bio-nanotechnologies which are coupled with nano particulates, polymers, Liposome, variousgold plated and Solid Lipids Particulates regulate the transcellular transport, non specific cellular uptake,and paracellular transport, which leads to oral, transdermal, Pulmonary, buccal, Nasal, specificgene oriented administration to avoid the non patience compliance with the parental routes of administration.Phytochemicals have an emerging strategy for the future prospects of diabetes management | ||
| 700 | 1 | |a Trivedi, Riddhi |e verfasserin |4 aut | |
| 700 | 1 | |a Suman, Sonali |e verfasserin |4 aut | |
| 700 | 1 | |a Kukrety, Arvind |e verfasserin |4 aut | |
| 700 | 1 | |a Prajapati, Prajesh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Mini-reviews in ... medicinal chemistry |d Hilversum, the Netherlands [u.a.] : Bentham Science Publ., 2001 |g 22(2022), 1, Seite 26 |h Online-Ressource |w (DE-627)KFL000006394 |w (DE-600)2104083-7 |w (DE-576)273887203 |x 1875-5607 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:1 |g pages:26 |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=1389-5575&volume=22&issue=1&spage=89 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-BEJ | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_DARH_03 | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 1 |h 26 | ||